The Alzheimer's Disease Assessment Scale, was designed specifically to evaluate the severity of cognitive and noncognitive behavioral dysfunctions characteristic of persons with Alzheimer's disease. The cognitive subscale comprises:
1. Spoken language ability
2. Comprehension of spoken language
3. Recall of test instructions
4. Word-finding difficulty
5. Following commands
6. Naming objects and fingers
7. Constructional praxis (drawing)
8. Ideational praxis
9. Orientation
10. Word recall
11. Word recognition
Items 1-4 are based on the tester's observations throughout the session. The other items are based on specific tasks.
Definition contributed by Anonymous
1. Spoken language ability
2. Comprehension of spoken language
3. Recall of test instructions
4. Word-finding difficulty
5. Following commands
6. Naming objects and fingers
7. Constructional praxis (drawing)
8. Ideational praxis
9. Orientation
10. Word recall
11. Word recognition
Items 1-4 are based on the tester's observations throughout the session. The other items are based on specific tasks.
Definition contributed by Anonymous
Constituent Tasks
orientation test
ideational praxis task
following commands
word recognition task
drawing
object naming task
free word list recall
Constituent Battery
No batteries have been added.
orientation test
ideational praxis task
following commands
word recognition task
drawing
object naming task
free word list recall
Constituent Battery
No batteries have been added.
INDICATORS
No indicators have yet been associated.
An indicator is a specific quantitative or qualitative variable that is recorded for analysis. These may include behavioral variables (such as response time, accuracy, or other measures of performance) or physiological variables (including genetics, psychophysiology, or brain imaging data).
Term BIBLIOGRAPHY
A new rating scale for Alzheimer's disease.
Rosen WG, Mohs RC, Davis KL
The American journal of psychiatry (Am J Psychiatry)
1984 Nov
Rosen WG, Mohs RC, Davis KL
The American journal of psychiatry (Am J Psychiatry)
1984 Nov
Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study.
Mohs RC, Knopman D, Petersen RC, Ferris SH, Ernesto C, Grundman M, Sano M, Bieliauskas L, Geldmacher D, Clark C, Thal LJ
(Alzheimer Dis Assoc Disord)
1997
Mohs RC, Knopman D, Petersen RC, Ferris SH, Ernesto C, Grundman M, Sano M, Bieliauskas L, Geldmacher D, Clark C, Thal LJ
(Alzheimer Dis Assoc Disord)
1997
Email: contact@cognitiveatlas.org